Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 356

1.

Effectiveness of radiation for prevention of mastectomy in older breast cancer patients treated with conservative surgery.

Albert JM, Pan IW, Shih YC, Jiang J, Buchholz TA, Giordano SH, Smith BD.

Cancer. 2012 Oct 1;118(19):4642-51. doi: 10.1002/cncr.27457. Epub 2012 Aug 13.

2.

Effectiveness of radiation therapy for older women with early breast cancer.

Smith BD, Gross CP, Smith GL, Galusha DH, Bekelman JE, Haffty BG.

J Natl Cancer Inst. 2006 May 17;98(10):681-90.

PMID:
16705122
3.

Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy.

Abdulkarim BS, Cuartero J, Hanson J, Deschênes J, Lesniak D, Sabri S.

J Clin Oncol. 2011 Jul 20;29(21):2852-8. doi: 10.1200/JCO.2010.33.4714. Epub 2011 Jun 13.

4.

Radiation therapy use and outcomes among older women with ER-positive and ER-negative stage I breast cancer.

Shen X, Anne PR, Keith SW, Wojcieszynski A, Mishra MV, Bar-Ad V, Showalter TN.

Am J Clin Oncol. 2014 Jun;37(3):241-7. doi: 10.1097/COC.0b013e318271b326.

PMID:
23241502
6.

Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.

Madden NA, Macdonald OK, Call JA, Schomas DA, Lee CM, Patel S.

Am J Clin Oncol. 2016 Oct;39(5):458-62. doi: 10.1097/COC.0000000000000078.

PMID:
24781343
7.

Impact of evidence-based clinical guidelines on the adoption of postmastectomy radiation in older women.

Shirvani SM, Pan IW, Buchholz TA, Shih YC, Hoffman KE, Giordano SH, Smith BD.

Cancer. 2011 Oct 15;117(20):4595-605. doi: 10.1002/cncr.26081. Epub 2011 Jun 27.

8.

Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.

Worni M, Akushevich I, Greenup R, Sarma D, Ryser MD, Myers ER, Hwang ES.

J Natl Cancer Inst. 2015 Sep 30;107(12):djv263. doi: 10.1093/jnci/djv263. Print 2015 Dec.

9.

Benefit of adjuvant radiotherapy after breast-conserving therapy among elderly women with T1-T2N0 estrogen receptor-negative breast cancer.

Eaton BR, Jiang R, Torres MA, Kahn ST, Godette K, Lash TL, Ward KC.

Cancer. 2016 Oct;122(19):3059-68. doi: 10.1002/cncr.30142. Epub 2016 Jun 21.

10.

Older Patients With Early-stage Breast Cancer: Adjuvant Radiation Therapy and Predictive Factors for Cancer-related Death.

Nagar H, Yan W, Christos P, Chao KSC, Nori D, Ravi A.

Am J Clin Oncol. 2017 Jun;40(3):300-305. doi: 10.1097/COC.0000000000000144.

PMID:
25333731
11.

Nomogram to predict the benefit of radiation for older patients with breast cancer treated with conservative surgery.

Albert JM, Liu DD, Shen Y, Pan IW, Shih YC, Hoffman KE, Buchholz TA, Giordano SH, Smith BD.

J Clin Oncol. 2012 Aug 10;30(23):2837-43. doi: 10.1200/JCO.2011.41.0076. Epub 2012 Jun 25.

12.

Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.

Truong PT, Olivotto IA, Kader HA, Panades M, Speers CH, Berthelet E.

Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1337-47.

PMID:
15817335
13.

Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: patterns of failure and prognostic factors.

Chen X, Yu X, Chen J, Zhang Z, Tuan J, Shao Z, Guo X, Feng Y.

Cancer. 2013 Jul 1;119(13):2366-74. doi: 10.1002/cncr.28085. Epub 2013 Apr 10.

14.

Disparities in breast cancer treatment and survival for women with disabilities.

McCarthy EP, Ngo LH, Roetzheim RG, Chirikos TN, Li D, Drews RE, Iezzoni LI.

Ann Intern Med. 2006 Nov 7;145(9):637-45.

15.

Effectiveness of radiation therapy in older women with ductal carcinoma in situ.

Smith BD, Haffty BG, Buchholz TA, Smith GL, Galusha DH, Bekelman JE, Gross CP.

J Natl Cancer Inst. 2006 Sep 20;98(18):1302-10.

PMID:
16985249
16.

Diminished survival in patients with inner versus outer quadrant breast cancers.

Gaffney DK, Tsodikov A, Wiggins CL.

J Clin Oncol. 2003 Feb 1;21(3):467-72.

PMID:
12560437
17.

CDO1 promoter methylation is a biomarker for outcome prediction of anthracycline treated, estrogen receptor-positive, lymph node-positive breast cancer patients.

Dietrich D, Krispin M, Dietrich J, Fassbender A, Lewin J, Harbeck N, Schmitt M, Eppenberger-Castori S, Vuaroqueaux V, Spyratos F, Foekens JA, Lesche R, Martens JW.

BMC Cancer. 2010 Jun 1;10:247. doi: 10.1186/1471-2407-10-247.

18.

Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke.

Woodward WA, Giordano SH, Duan Z, Hortobagyi GN, Buchholz TA.

Cancer. 2006 Jun 15;106(12):2556-62.

19.

Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.

Ellis MJ, Tao Y, Luo J, A'Hern R, Evans DB, Bhatnagar AS, Chaudri Ross HA, von Kameke A, Miller WR, Smith I, Eiermann W, Dowsett M.

J Natl Cancer Inst. 2008 Oct 1;100(19):1380-8. doi: 10.1093/jnci/djn309. Epub 2008 Sep 23.

20.

The evolving role of adjuvant radiotherapy for elderly women with early-stage breast cancer.

Rutter CE, Lester-Coll NH, Mancini BR, Corso CD, Park HS, Yeboa DN, Gross CP, Evans SB.

Cancer. 2015 Jul 15;121(14):2331-40. doi: 10.1002/cncr.29377. Epub 2015 Mar 24.

Supplemental Content

Support Center